<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03441074</url>
  </required_header>
  <id_info>
    <org_study_id>dsyy003</org_study_id>
    <nct_id>NCT03441074</nct_id>
  </id_info>
  <brief_title>Olfactory Function and Postoperative Cognitive Dysfunction</brief_title>
  <official_title>Effects of Enriched Olfactory Stimuli on Postoperative Cognitive Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the correlation of POCD with olfactory function. To explore whether enhanced
      olfactory stimuli can reduce the risk of POCD as a preventive strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative cognitive dysfunction (POCD), the most common complications of geriatric
      surgical patients, could contribute to long-term social dysfunction, high mortality and
      increased medical cost. Previous studies have suggested that impaired Olfaction was related
      to postoperative delirium (Nadya M. Dhanani et al, J Clin Anesth 2012; Charles H. Brown IV et
      al, J Am Geriatr So 2015; Min Seung Kim et al, J Neural Transm 2016). However, there is still
      no efficient treatment for POCD, and it also remains largely unknown whether enhanced
      olfactory stimuli can be used as an inventive strategy to reduce the risk of POCD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preoperative cognitive function</measure>
    <time_frame>1 day before surgery (baseline)</time_frame>
    <description>The neuropsychological tests to assess preoperative cognitive function at baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Preoperative olfactory function</measure>
    <time_frame>1 day before surgery (baseline)</time_frame>
    <description>The olfactory tests to assess preoperative olfactory function at baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative cognitive function</measure>
    <time_frame>7 days after surgery (folow-up)</time_frame>
    <description>The neuropsychological tests to assess postoperative cognitive function at follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative olfactory function</measure>
    <time_frame>7 days after surgery (folow-up)</time_frame>
    <description>The olfactory tests to assess preoperative olfactory function at follow-up</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomly assigned to intervention group will get enhanced olfactory stimuli during the perioperative period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-intervention Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients randomly assigned to non-intervention group will not get any olfactory stimuli during the perioperative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>enhanced olfactory stimuli</intervention_name>
    <description>Patients in intervention group will get enhanced olfactory stimuli during perioperative period (7 days before and after the surgery), by using portable scented sachets.</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Keen surgery under general anesthesia;

          2. Age is greater than or equal to 65 years old;

          3. Han Nationality, mother tongue is chinese;

          4. The MMSE score: Illiteracy is greater than or equal to 17 points, primary school is
             greater than or equal to 20 points, higher secondary school is more than 24 points;

          5. Being able to complete the assessments without serious visual or hearing difficulty;

          6. Without serious heart, brain, liver, kidney, lung and other organs;

          7. Without serious neurological and psychiatric disorders, such as Alzheimer's disease,
             Parkinson's syndrome, multiple sclerosis, schizophrenia, depression, etc.;

          8. The ASA class I or II;

          9. The people signed informed consent.

        Exclusion Criteria:

          1. Had severe head and face disease, trauma history or history of surgery;

          2. Had a history of influenza in 3 weeks;

          3. The serious body disease and tobacco, wine and other substance abuse history;

          4. The presence of malignant tumor with shorter survival disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuan Shen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai 10th People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuan Shen, MD, PhD</last_name>
    <phone>2166303649</phone>
    <email>kmshy@tongji.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhongyong Shi, MD</last_name>
    <phone>18701915271</phone>
    <email>szy0721@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Tenth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanxia Guo, M.D.</last_name>
      <phone>021-65982875</phone>
      <email>guoyx_2000@tongji.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Kim MS, Yoon JH, Kim HJ, Yong SW, Hong JM. Olfactory dysfunction is related to postoperative delirium in Parkinson's disease. J Neural Transm (Vienna). 2016 Jun;123(6):589-94. doi: 10.1007/s00702-016-1555-0. Epub 2016 Apr 20.</citation>
    <PMID>27098668</PMID>
  </results_reference>
  <results_reference>
    <citation>Brown CH 4th, Morrissey C, Ono M, Yenokyan G, Selnes OA, Walston J, Max L, LaFlam A, Neufeld K, Gottesman RF, Hogue CW. Impaired olfaction and risk of delirium or cognitive decline after cardiac surgery. J Am Geriatr Soc. 2015 Jan;63(1):16-23. doi: 10.1111/jgs.13198.</citation>
    <PMID>25597555</PMID>
  </results_reference>
  <results_reference>
    <citation>Dhanani NM, Jiang Y. Anosmia and hypogeusia as a complication of general anesthesia. J Clin Anesth. 2012 May;24(3):231-3. doi: 10.1016/j.jclinane.2011.08.005. Epub 2012 Apr 9.</citation>
    <PMID>22495083</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2018</study_first_submitted>
  <study_first_submitted_qc>February 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2018</study_first_posted>
  <last_update_submitted>April 21, 2018</last_update_submitted>
  <last_update_submitted_qc>April 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Yuan Shen, MD, PhD</investigator_full_name>
    <investigator_title>Chief of Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

